Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9

被引：160
|
作者：
Zhang, Hong-Xia [1 ,2 ]
Zhang, Ying [2 ]
Yin, Hao [1 ,2 ]
机构：
[1] Wuhan Univ, Zhongnan Hosp, Dept Urol, Wuhan 430071, Hubei, Peoples R China
[2] Wuhan Univ, Med Res Inst, Donghu Rd 115,Bldg 8, Wuhan 430071, Hubei, Peoples R China
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
基金：
中国国家自然科学基金;
关键词：
ONE-STEP GENERATION; IN-VIVO; HEMATOPOIETIC STEM; GENE DELIVERY; RESTRICTION ENZYMES; GUIDED ENDONUCLEASE; CATIONIC POLYMERS; NONVIRAL VECTORS; DNA; EFFICIENT;
D O I：
10.1016/j.ymthe.2019.01.014
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Genome-editing technologies based on programmable nucleases have significantly broadened our ability to make precise and direct changes in the genomic DNA of various species, including human cells. Delivery of programmable nucleases into the target tissue or cell is one of the pressing challenges in transforming the technology into medicine. In vitro-transcribed (IVT) mRNA-mediated delivery of nucleases has several advantages, such as transient expression with efficient in vivo and in vitro delivery, no genomic integration, a potentially low off-target rate, and high editing efficiency. This review focuses on key barriers related to IVT mRNA delivery, on developed modes of delivery, and on the application and future prospects of mRNA encoding nuclease-mediated genome editing in research and clinical trials.
引用
收藏
页码：735 / 746
页数：12
相关论文
共 50 条
  • [21] Orthogonal Cas9–Cas9 chimeras provide a versatile platform for genome editing
    Mehmet Fatih Bolukbasi
    Pengpeng Liu
    Kevin Luk
    Samantha F. Kwok
    Ankit Gupta
    Nadia Amrani
    Erik J. Sontheimer
    Lihua Julie Zhu
    Scot A. Wolfe
    Nature Communications, 9
  • [22] A Report of applying TALEN and CRISPR/Cas9 genome-editing technologies to five genes on mouse zygotes
    Chang, Sheng-Kai
    Yu, I-Shing
    Pu, Feng-Lin
    Wu, Po-Yuen
    Lin, Shu-Wha
    TRANSGENIC RESEARCH, 2014, 23 (05) : 874 - 875
  • [23] Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing
    Wei Yan
    Cory Smith
    Linzhao Cheng
    Scientific Reports, 3
  • [24] Analysis of the effect on HBV life cycle by HBV genome editing using TALEN and CRISPR/Cas9 systems
    Abe, Hiromi
    Sakuma, Tetsushi
    Tsuge, Masataka
    Hiraga, Nobuhiko
    Imamura, Michio
    Hayes, C. Nelson
    Aikata, Hiroshi
    Yamamoto, Takashi
    Chayama, Kazuaki
    HEPATOLOGY, 2014, 60 : 1028A - 1028A
  • [25] Targeted Genome Modifications in Sugarcane with CRISPR/Cas9 and TALEN.
    Altpeter, Fredy
    Jung, Je Hyeong
    Oz, Tufan Mehmet
    Karan, Ratna
    Merotto, Aldo
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2016, 52 : S19 - S20
  • [26] Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing
    Yan, Wei
    Smith, Cory
    Cheng, Linzhao
    SCIENTIFIC REPORTS, 2013, 3
  • [27] ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
    Gaj, Thomas
    Gersbach, Charles A.
    Barbas, Carlos F., III
    TRENDS IN BIOTECHNOLOGY, 2013, 31 (07) : 397 - 405
  • [28] CRISPR/CAS9 GENOME EDITING FOR NEURODEGENERATIVE DISEASES
    Nojadeh, Jafar Nouri
    Eryilmaz, Nur Seren Bildiren
    Erguder, Berrin Imge
    EXCLI JOURNAL, 2023, 22 : 567 - 582
  • [29] CRISPR/CAS9, the king of genome editing tools
    A. V. Bannikov
    A. V. Lavrov
    Molecular Biology, 2017, 51 : 514 - 525
  • [30] Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
    Duan, Li
    Ouyang, Kan
    Xu, Xiao
    Xu, Limei
    Wen, Caining
    Zhou, Xiaoying
    Qin, Zhuan
    Xu, Zhiyi
    Sun, Wei
    Liang, Yujie
    FRONTIERS IN GENETICS, 2021, 12
12345